Medifast (MED) Share-based Compensation (2010 - 2026)

Medifast's Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• Quarterly Share-based Compensation fell 1.76% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (up 6.78% YoY) and the FY2025 annual result came in at $7.6 million, up 3.75% from the prior year.
• Share-based Compensation was $1.9 million for Q1 2026 at Medifast, down from $2.2 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $3.0 million in Q3 2022 and bottomed at $606000.0 in Q1 2023.
• A 5-year average of $2.1 million and a median of $2.3 million in 2022 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation surged 2863.0% — and 2024, when it slumped 77.35%.
• Medifast's Share-based Compensation stood at $2.9 million in 2022, then fell by 18.88% to $2.4 million in 2023, then dropped by 10.91% to $2.1 million in 2024, then rose by 1.88% to $2.2 million in 2025, then declined by 12.71% to $1.9 million in 2026.
• Business Quant data shows MED's Share-based Compensation at $1.9 million in Q1 2026, $2.2 million in Q4 2025, and $910000.0 in Q3 2025.